News | Interventional Radiology | July 03, 2019

Varian will add the Boston Scientific Portfolio of drug-loadable microsphere and bland embolic bead products for multidisciplinary integrated cancer care

Varian Purchasing Embolic Bead Assets from Boston Scientific

July 3, 2019 — Varian announced it has signed an asset purchase agreement to acquire the Boston Scientific portfolio of drug-loadable microsphere and bland embolic bead products for treating arteriovenous malformations and hypervascular tumors. When completed, this acquisition, in combination with the recent acquisitions of Endocare and Alicon, will expand Varian's portfolio of multidisciplinary integrated cancer care solutions.

Varian's planned acquisition of the Boston Scientific portfolio of drug-loadable microsphere (Oncozene/Embozene Tandem) and bland embolic (Embozene) bead products will enable Varian to extend its new interventional oncology platform. The company will benefit from the products' regulatory clearances in more than 35 countries worldwide.

Varian will not acquire any of the Boston Scientific operations. While Varian implements a plan to manufacture and distribute these products, it will work with Boston Scientific under transition services agreements to ensure uninterrupted delivery to customers.

Varian is financing the purchase price of $90 million using cash and proceeds from borrowings. The transaction, which is expected to close around August 2019, is subject to the satisfaction or waiver of customary closing conditions, including approval of the U.S. Federal Trade Commission and the closing of the proposed acquisition of BTG PLC by Boston Scientific Corp.

The combined assets generated revenue of $21.2 million in calendar 2018. Varian expects this transaction to have an immaterial impact on fiscal year 2019 financial results, and the assets to be accretive to GAAP and Non-GAAP earnings per share in fiscal 2020.

For more information: www.varian.com


Related Content

Feature | RSNA | Christine Book

November 8, 2023 — Prepping for another strong meeting, the planners of "RSNA 2023: Leading through Change", presented ...

Time November 08, 2023
arrow
Feature | ACR | By Christine Book

October 31, 2023 — As another Breast Cancer Awareness Month comes to a close, Imaging Technology News is sharing ...

Time October 31, 2023
arrow
News | Artificial Intelligence

September 7, 2023 — Paige, a provider of end-to-end digital pathology solutions and clinical AI, has announced a ...

Time September 07, 2023
arrow
News | Radiology Business

July 27, 2023 — Privately-held biotech company TAE Life Sciences has announced that its board of directors has appointed ...

Time July 27, 2023
arrow
News | Radiation Therapy

July 21, 2023 — RefleXion Medical, a therapeutic oncology company, today announced that researchers from multiple ...

Time July 21, 2023
arrow
News | Oncology Information Management Systems (OIMS)

July 21, 2023 — A key feature of RayCare 2023B is the enhanced fully integrated management of radiotherapy treatment ...

Time July 21, 2023
arrow
News | AAPM

July 21, 2023 — The 65th Annual Meeting and Exhibition of the American Association of Physicists in Medicine, AAPM 2023 ...

Time July 20, 2023
arrow
Feature | AAPM | By Melinda Taschetta-Millane

The American Association of Physicists in Medicine’s (AAPM) 65th annual meeting and exhibition will take place July 23 ...

Time July 18, 2023
arrow
News | Radiology Business

June 6, 2023 — RaySearch Laboratories has announced that New York University (NYU) Langone Hospital - Long Island ...

Time June 06, 2023
arrow
News | Artificial Intelligence

May 4, 2023 — DeepTek.ai, A Pune, India-based radiology artificial intelligence (AI) company, has announced that its AI ...

Time May 04, 2023
arrow
Subscribe Now